Psoriatic Arthritis
Psoriatic arthritis (PsA) is a chronic autoimmune condition that causes inflammation in the joints and is often associated with the skin condition psoriasis, leading to symptoms like joint pain, stiffness, and swelling.
Guselkumab for Active Psoriatic Arthritis Axial Disease
We are studying whether guselkumab can help reduce symptoms in people with active psoriatic arthritis axial disease who have not been treated before. Participants will receive either the medication or a placebo.
1-2 years6-10 visitsMonitoring phase (IV)Cost ReimbursementPartially RemoteStandard MedicinesInjectionInternal MedicineRheumatology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have a diagnosis of Psoriatic Arthritis (PsA) for at least 6 months?
- Do you have at least 3 swollen joints and at least 3 tender joints?
- Have you had a serious infection or been hospitalized for an infection in the last 2 months?
- Have you received any biologic treatment for PsA before?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical Center Artmed Ltd.
Not applicable
Haskovo, Bulgaria
Medical Center Exacta Medica OOD
Not applicable
Pleven, Bulgaria
University Multiprofile Hospital For Active Treatment Dr. Georgi Stranski EAD
Rheumatology Clinic
Pleven, Bulgaria
Sponsor: Janssen - Cilag International
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.